References

1. Bosman FT. WHO classification of tumours of the digestive system. Lyon: IARC Press, 2010.
2. Lim JH, Lee G, Oh YL. Radiologic spectrum of intraductal papillary mucinous tumor of the pancreas. Radiographics 2001;21(2):323-337; discussion 337-340. doi: 10.1148/radiographics.21.2.g01mr01323.
3. Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA, WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020;76(2):182–188. doi: 10.1111/his.13975.
4. Megibow AJ, Baker ME, Morgan DE, Kamel IR, Sahani DV, Newman E, Brugge WR, Berland LL, Pandharipande PV. Management of incidental pancreatic cysts: A white paper of the ACR incidental findings committee. J Am Coll Radiol 2017;14(7):911-923. doi: 10.1016/j.jacr.2017.03.010.
5. European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018;67(5):789-804. doi: 10.1136/gutjnl-2018-316027.
6. Singhi AD, Zeh HJ, Brand RE, Nikiforova MN, Chennat JS, Fasanella KE, Khalid A, Papachristou GI, Slivka A, Hogg M, Lee KK, Tsung A, Zureikat AH, McGrath K. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data. Gastrointest Endosc 2016;83(6):1107–1117.e2. doi: 10.1016/j.gie.2015.12.009.
7. Tanaka M, Fernández-Del Castillo C, Kamisawa T, Jang JY, Levy P, Ohtsuka T, Salvia R, Shimizu Y, Tada M, Wolfgang CL. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017;17(5):738-753. doi: 10.1016/j.pan.2017.07.007.
8. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S, International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6(1-2):17-32. doi: 10.1159/000090023.
9. Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, Kimura W, Levy P, Pitman MB, Schmidt CM, Shimizu M, Wolfgang CL, Yamaguchi K, Yamao K, International Association of Pancreatology. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12(3):183-197. doi: 10.1016/j.pan.2012.04.004.
10. Choi SY, Kim JH, Yu MH, Eun HW, Lee HK, Han JK. Diagnostic performance and imaging features for predicting the malignant potential of intraductal papillary mucinous neoplasm of the pancreas: a comparison of EUS, contrast-enhanced CT and MRI. Abdom Radiol (NY) 2017;42(5):1449-1458. doi: 10.1007/s00261-017-1053-3.
11. Lee JE, Choi SY, Min JH, Yi BH, Lee MH, Kim SS, Hwang JA, Kim JH. Determining Malignant Potential of intraductal Papillary Mucinous neoplasm of the Pancreas: CT versus MRI by Using revised 2017 International Consensus Guidelines. Radiology 2019;293(1):134-143. doi: 10.1148/radiol.2019190144.
12. Min JH, Kim YK, Kim SK, Kim H, Ahn S. Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI. Eur Radiol 2021;31(7):4774-4784. doi: 10.1007/s00330-020-07583-1.
13. Hong SB, Lee NK, Kim S, Seo HI, Park YM, Noh BG, Kim DU, Han SY, Kim TU. Diagnostic performance of magnetic resonance image for malignant intraductal papillary mucinous neoplasms: the importance of size of enhancing mural nodule within cyst. Jpn J Radiol 2022;40(12):1282-1289. doi: 10.1007/s11604-022-01312-y.
14. Scherer JA, Gebhard R, Firkins SA, Shah ZK, Urbina Andersson IK, Barker SJ, Fiorillo LE, Hollander E, Shaheen N, Koay EJ, Conwell DL, Krishna SG. Lower Interobserver reliability for nondimensional intracystic features among abdominal radiologists for characterizing intraductal papillary mucinous neoplasms using magnetic resonance imaging. Pancreas 2022;51(9):1225-1230. doi: 10.1097/MPA.0000000000002174.
15. Choi SY, Min JH, Kim JH, Park HJ, Kim YY, Han YE, Bae SH, Lee JH, Choi YH, Moon JE. Interobserver variability and diagnostic performance in predicting malignancy of pancreatic intraductal papillary mucinous neoplasm with MRI. Radiology 2023;308(1):e222463. doi: 10.1148/radiol.222463.
16. Vege SS, Ziring B, Jain R, Moayyedi P, Clinical Guidelines Committee, American Gastroenterology Association. American Gastroenterological Association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 2015;148(4):819-822; quize812-813. doi: 10.1053/j.gastro.2015.01.015.
17. Kang HJ, Lee JM, Joo I, Hur BY, Jeon JH, Jang JY, Lee K, Ryu JK, Han JK, Choi BI. Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas: comparison between multidetector CT and MR imaging with MR cholangiopancreatography. Radiology 2016;279(1):128-139. doi: 10.1148/radiol.2015150217.
18. Kim SW, Kim SH, Lee DH, Lee SM, Kim YS, Jang JY, Han JK. Isolated main pancreatic duct dilatation: CT differentiation between benign and malignant causes. AJR Am J Roentgenol 2017;209(5):1046-1055. doi: 10.2214/AJR.17.17963.
19. Hwang JA, Choi SY, Lee JE, Kim SS, Lee S, Moon JY, Heo NH. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline. Eur Radiol 2020;30(7):3711-3722. doi: 10.1007/s00330-020-06736-6.
20. Marchegiani G, Andrianello S, Borin A, Dal Borgo C, Perri G, Pollini T, Romanò G, D'Onofrio M, Gabbrielli A, Scarpa A, Malleo G, Bassi C, Salvia R. Systematic review, meta-analysis, and a high-volume center experience supporting the new role of mural nodules proposed by the updated 2017 international guidelines on IPMN of the pancreas. Surgery 2018;163(6):1272-1279. doi: 10.1016/j.surg.2018.01.009.
21. Ogawa H, Itoh S, Ikeda M, Suzuki K, Naganawa S. Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT. Radiology 2008;248(3):876-886. doi: 10.1148/radiol.2482071578.
22. Do RKG, Katz SS, Gollub MJ, Li J, LaFemina J, Zabor EC, Moskowitz CS, Klimstra DS, Allen PJ. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT. AJR Am J Roentgenol 2014;203(5):973-979. doi: 10.2214/AJR.13.11490.
23. Kim SH, Lee JM, Lee ES, Baek JH, Kim JH, Han JK, Choi BI. Intraductal papillary mucinous neoplasms of the pancreas: evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology 2015;274(3):723-733. doi: 10.1148/radiol.14132960.